Skip to main content
Top
Gepubliceerd in: Quality of Life Research 7/2009

01-09-2009

Predicting EQ-5D utility scores from the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ 25) in patients with age-related macular degeneration

Auteurs: Nalin Payakachat, Kent H. Summers, Andreas M. Pleil, Matthew M. Murawski, Joseph Thomas III, Kristofer Jennings, James G. Anderson

Gepubliceerd in: Quality of Life Research | Uitgave 7/2009

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

In this study, we explored different statistical approaches to identify the best algorithm to predict EQ-5D utility scores from the NEI-VFQ 25 in patients with age-related macular degeneration (AMD).

Methods

Ordinary least squares (OLS), Tobit, and censored least absolute deviation (CLAD) approaches were compared using cross-sectional data (primary dataset, n = 151) at screening from a phase I/II clinical trial in patients with AMD. Three models were specified in this study: full (includes all 12 dimensions of the NEI-VFQ 25), short (includes only the general health dimension and the composite score), and reduced model (using stepwise regression). To evaluate the predictive accuracy of the models, the mean absolute prediction error (MAPE), mean error, and root means squared error were calculated using in-sample cross-validation (within the primary dataset) and out-of-sample validation using an independent dataset (n = 393). The model that provided the lowest prediction errors was chosen as the best model.

Results

In-sample cross-validation and out-of-sample validation consistently demonstrated that, compared to other approaches, heteroscedasticity-adjusted OLS produced the lowest MAPE (mean values were 0.1400, 0.1593, respectively) for the full model, while CLAD performed best for the short and reduced models (mean values were 0.1299, 0.1483, respectively). The normality and homoscedasticity assumptions of both OLS and Tobit were rejected. CLAD, however, can accommodate these particular violations.

Conclusions

The CLAD-short model is recommended for producing the EQ-5D utility scores when only the NEI-VFQ 25 data are available.
Literatuur
2.
go back to reference Resnikoff, S., Pascolini, D., Etya’ale, D., et al. (2004). Global data on visual impairment in the year 2002. Bulletin of the World Health Organization, 82(11), 844–851.PubMed Resnikoff, S., Pascolini, D., Etya’ale, D., et al. (2004). Global data on visual impairment in the year 2002. Bulletin of the World Health Organization, 82(11), 844–851.PubMed
3.
go back to reference The Eye Diseases Prevalence Research Group. (2004). Causes and prevalence of visual impairment among adults in the United States. Archives of Ophthalmology, 122(4), 477–485.CrossRef The Eye Diseases Prevalence Research Group. (2004). Causes and prevalence of visual impairment among adults in the United States. Archives of Ophthalmology, 122(4), 477–485.CrossRef
4.
go back to reference Leibowitz, H. M., Krueger, D. E., Maunder, L. R., et al. (1980). The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Survey of Ophthalmology, 24((Suppl)), 335–610.PubMed Leibowitz, H. M., Krueger, D. E., Maunder, L. R., et al. (1980). The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Survey of Ophthalmology, 24((Suppl)), 335–610.PubMed
5.
go back to reference Vingerling, J. R., Dielemans, I., Hofman, A., et al. (1995). The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology, 102(2), 205–210.PubMed Vingerling, J. R., Dielemans, I., Hofman, A., et al. (1995). The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology, 102(2), 205–210.PubMed
6.
go back to reference Bressler, N. M. (2001). Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Archives of Ophthalmology, 119(2), 198–207.PubMed Bressler, N. M. (2001). Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Archives of Ophthalmology, 119(2), 198–207.PubMed
7.
go back to reference Ubel, P. A., Loewenstein, G., & Jepson, C. (2003). Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Quality of Life Research, 12(6), 599–607.PubMedCrossRef Ubel, P. A., Loewenstein, G., & Jepson, C. (2003). Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Quality of Life Research, 12(6), 599–607.PubMedCrossRef
8.
go back to reference Fryback, D. G. (2003). Whose quality of life? or Whose decision? Quality of Life Research, 12(6), 609–610.PubMedCrossRef Fryback, D. G. (2003). Whose quality of life? or Whose decision? Quality of Life Research, 12(6), 609–610.PubMedCrossRef
9.
go back to reference Brazier, J., Akehurst, R., Brennan, A., et al. (2005). Should patients have a greater role in valuing health states? Applied Health Economics and Health Policy, 4, 201–208.PubMedCrossRef Brazier, J., Akehurst, R., Brennan, A., et al. (2005). Should patients have a greater role in valuing health states? Applied Health Economics and Health Policy, 4, 201–208.PubMedCrossRef
11.
go back to reference The EuroQoL Group. (1990). EuroQol—a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy, 16(3), 199–208.CrossRef The EuroQoL Group. (1990). EuroQol—a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy, 16(3), 199–208.CrossRef
12.
go back to reference Gold, M. R., Patrick, D. L., & Torrance, G. W. (1996). Identifying and valuing outcomes. In M. R. Gold, J. E. Siegel, L. B. Russell, M. C. Weinstein, et al. (Eds.), Cost-effectiveness in health and medicine (pp. 82–134). New York: Oxford University Press. Gold, M. R., Patrick, D. L., & Torrance, G. W. (1996). Identifying and valuing outcomes. In M. R. Gold, J. E. Siegel, L. B. Russell, M. C. Weinstein, et al. (Eds.), Cost-effectiveness in health and medicine (pp. 82–134). New York: Oxford University Press.
13.
go back to reference Drummond, M. F., O’Brien, B., Stoddart, G. L., & Torrance, G. W. (1997). Methods for the economic evaluation of health care programmes (2nd ed.). Oxford: Oxford Medical Publications. Drummond, M. F., O’Brien, B., Stoddart, G. L., & Torrance, G. W. (1997). Methods for the economic evaluation of health care programmes (2nd ed.). Oxford: Oxford Medical Publications.
14.
go back to reference Mangione, C. M., Lee, P. P., Gutierrez, P. R., et al. (2001). Development of the 25-item National Eye Institute Visual Function Questionnaire. Archives of Ophthalmology, 119(7), 1050–1058.PubMed Mangione, C. M., Lee, P. P., Gutierrez, P. R., et al. (2001). Development of the 25-item National Eye Institute Visual Function Questionnaire. Archives of Ophthalmology, 119(7), 1050–1058.PubMed
15.
go back to reference Chia, E. M., Mitchell, P., Ojaimi, E., et al. (2006). Assessment of vision-related quality of life in an older population subsample: The Blue Mountains Eye Study. Ophthalmic Epidemiology, 13(6), 371–377.PubMedCrossRef Chia, E. M., Mitchell, P., Ojaimi, E., et al. (2006). Assessment of vision-related quality of life in an older population subsample: The Blue Mountains Eye Study. Ophthalmic Epidemiology, 13(6), 371–377.PubMedCrossRef
16.
go back to reference Hudson, H. L., Lane, S. S., Heier, J. S., et al. (2006). Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results. Ophthalmology, 113(11), 1987–2001.PubMedCrossRef Hudson, H. L., Lane, S. S., Heier, J. S., et al. (2006). Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results. Ophthalmology, 113(11), 1987–2001.PubMedCrossRef
17.
go back to reference Ringsdorf, L., McGwin, G., & Owsley, C. (2006). Visual field defects and vision-specific health-related quality of life in African Americans and whites with glaucoma. Journal of Glaucoma, 15(5), 414–418.PubMedCrossRef Ringsdorf, L., McGwin, G., & Owsley, C. (2006). Visual field defects and vision-specific health-related quality of life in African Americans and whites with glaucoma. Journal of Glaucoma, 15(5), 414–418.PubMedCrossRef
18.
go back to reference Varma, R., Wu, J., Chong, K., et al. (2006). Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology, 113(10), 1846–1853.PubMedCrossRef Varma, R., Wu, J., Chong, K., et al. (2006). Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology, 113(10), 1846–1853.PubMedCrossRef
20.
go back to reference Age-Related Eye Disease Study Research Group. (2005). Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS report no. 14. Archives of Ophthalmology, 123(9), 1207–1214.CrossRef Age-Related Eye Disease Study Research Group. (2005). Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS report no. 14. Archives of Ophthalmology, 123(9), 1207–1214.CrossRef
21.
go back to reference Finger, R., Fleckenstein, M., Holz, F., & Scholl, H. (2008). Quality of life in age-related macular degeneration: A review of available vision-specific psychometric tools. Quality of Life Research, 17(4), 559–574.PubMedCrossRef Finger, R., Fleckenstein, M., Holz, F., & Scholl, H. (2008). Quality of life in age-related macular degeneration: A review of available vision-specific psychometric tools. Quality of Life Research, 17(4), 559–574.PubMedCrossRef
22.
go back to reference Austin, P. C. (2002). Bayesian extensions of the Tobit model for analyzing measures of health status. Medical Decision Making, 22(2), 152–162.PubMed Austin, P. C. (2002). Bayesian extensions of the Tobit model for analyzing measures of health status. Medical Decision Making, 22(2), 152–162.PubMed
23.
go back to reference Sullivan, P. W., Lawrence, W. F., & Ghushchyan, V. (2005). A national catalog of preference-based scores for chronic conditions in the United States. Medical Care, 43(7), 736–749.PubMedCrossRef Sullivan, P. W., Lawrence, W. F., & Ghushchyan, V. (2005). A national catalog of preference-based scores for chronic conditions in the United States. Medical Care, 43(7), 736–749.PubMedCrossRef
24.
go back to reference Sullivan, P. W., & Ghushchyan, V. (2006). Preference-based EQ-5D index scores for chronic conditions in the United States. Medical Decision Making, 26(4), 410–420.PubMedCrossRef Sullivan, P. W., & Ghushchyan, V. (2006). Preference-based EQ-5D index scores for chronic conditions in the United States. Medical Decision Making, 26(4), 410–420.PubMedCrossRef
25.
go back to reference Austin, P. C. (2002). A comparison of methods for analyzing health-related quality-of-life measures. Value in Health, 5(4), 329–337.PubMedCrossRef Austin, P. C. (2002). A comparison of methods for analyzing health-related quality-of-life measures. Value in Health, 5(4), 329–337.PubMedCrossRef
26.
go back to reference Fryback, D. G., Lawrence, W. F., Martin, P. A., et al. (1997). Predicting quality of well-being scores from the SF-36: Results from the Beaver Dam Health Outcomes Study. Medical Decision Making, 17(1), 1–9.PubMedCrossRef Fryback, D. G., Lawrence, W. F., Martin, P. A., et al. (1997). Predicting quality of well-being scores from the SF-36: Results from the Beaver Dam Health Outcomes Study. Medical Decision Making, 17(1), 1–9.PubMedCrossRef
27.
go back to reference Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21, 271–292.PubMedCrossRef Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21, 271–292.PubMedCrossRef
28.
go back to reference Franks, P., Lubetkin, E. I., Gold, M. R., et al. (2004). Mapping the SF-12 to the EuroQol EQ-5D Index in a national US sample. Medical Decision Making, 24(3), 247–254.PubMedCrossRef Franks, P., Lubetkin, E. I., Gold, M. R., et al. (2004). Mapping the SF-12 to the EuroQol EQ-5D Index in a national US sample. Medical Decision Making, 24(3), 247–254.PubMedCrossRef
29.
go back to reference Sullivan, P. W., & Ghushchyan, V. (2006). Mapping the EQ-5D Index from the SF-12: US general population preferences in a nationally representative sample. Medical Decision Making, 26(4), 401–409.PubMedCrossRef Sullivan, P. W., & Ghushchyan, V. (2006). Mapping the EQ-5D Index from the SF-12: US general population preferences in a nationally representative sample. Medical Decision Making, 26(4), 401–409.PubMedCrossRef
30.
go back to reference Gray, A. M., Rivero-Arias, O., & Clarke, P. M. (2006). Estimating the association between SF-12 responses and EQ-5D utility values by response mapping. Medical Decision Making, 26(1), 18–29.PubMedCrossRef Gray, A. M., Rivero-Arias, O., & Clarke, P. M. (2006). Estimating the association between SF-12 responses and EQ-5D utility values by response mapping. Medical Decision Making, 26(1), 18–29.PubMedCrossRef
31.
go back to reference Koltowska-Häggström, M., Jonsson, B., Isacson, D., & Bingefors, K. (2007). Using EQ-5D to derive general population-based utilities for the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA). Value in Health, 10, 73–81.PubMedCrossRef Koltowska-Häggström, M., Jonsson, B., Isacson, D., & Bingefors, K. (2007). Using EQ-5D to derive general population-based utilities for the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA). Value in Health, 10, 73–81.PubMedCrossRef
32.
go back to reference Buxton, M. J., Lacey, L. A., Feagan, B. G., et al. (2007). Mapping from disease-specific measures to utility: An analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn’s Disease Activity Index in Crohn’s disease and measures of utility. Value in Health, 10, 214–220.PubMedCrossRef Buxton, M. J., Lacey, L. A., Feagan, B. G., et al. (2007). Mapping from disease-specific measures to utility: An analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn’s Disease Activity Index in Crohn’s disease and measures of utility. Value in Health, 10, 214–220.PubMedCrossRef
33.
go back to reference Wu, E. Q., Mulani, P., Farrell, M. H., & Sleep, D. (2007). Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients. Value in Health, 10(5), 408–414.PubMedCrossRef Wu, E. Q., Mulani, P., Farrell, M. H., & Sleep, D. (2007). Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients. Value in Health, 10(5), 408–414.PubMedCrossRef
34.
go back to reference Dobrez, D., Cella, D., Pickard, A. S., et al. (2007). Estimation of patient preference-based utility weights from the functional assessment of cancer therapy-general. Value in Health, 10, 266–272.PubMedCrossRef Dobrez, D., Cella, D., Pickard, A. S., et al. (2007). Estimation of patient preference-based utility weights from the functional assessment of cancer therapy-general. Value in Health, 10, 266–272.PubMedCrossRef
35.
go back to reference Brazier, J. E., Yang, Y., & Tsuchiya, A. (2008). A review of studies mapping (or cross walking) from non-preference based measures of health to generic preference-based measures. UK: Health Economics and Decision Science (HEDS), School of Health and Related Research (ScHARR), University of Sheffield. Brazier, J. E., Yang, Y., & Tsuchiya, A. (2008). A review of studies mapping (or cross walking) from non-preference based measures of health to generic preference-based measures. UK: Health Economics and Decision Science (HEDS), School of Health and Related Research (ScHARR), University of Sheffield.
36.
go back to reference Nichol, M. B., Sengupta, N., & Globe, D. R. (2001). Evaluating quality-adjusted life years: Estimation of the Health Utility Index (HUI2) from the SF-36. Medical Decision Making, 21(2), 105–112.PubMed Nichol, M. B., Sengupta, N., & Globe, D. R. (2001). Evaluating quality-adjusted life years: Estimation of the Health Utility Index (HUI2) from the SF-36. Medical Decision Making, 21(2), 105–112.PubMed
37.
go back to reference Franks, P., Lubetkin, E. I., Gold, M. R., & Tancredi, D. J. (2003). Mapping the SF-12 to preference-based instruments: Convergent validity in a low-income, minority population. Medical Care, 41(11), 1277–1283.PubMedCrossRef Franks, P., Lubetkin, E. I., Gold, M. R., & Tancredi, D. J. (2003). Mapping the SF-12 to preference-based instruments: Convergent validity in a low-income, minority population. Medical Care, 41(11), 1277–1283.PubMedCrossRef
38.
go back to reference Powell, J. L. (1984). Least absolute deviations estimation for the censored regression model. Journal of Econometrics, 25(3), 303–325.CrossRef Powell, J. L. (1984). Least absolute deviations estimation for the censored regression model. Journal of Econometrics, 25(3), 303–325.CrossRef
39.
go back to reference Kennedy, P. (2003). Limited dependent variables. In P. Kennedy (Ed.), A guide to econometric (5th ed., pp. 281–284). Cambridge, MA: The MIT Press. Kennedy, P. (2003). Limited dependent variables. In P. Kennedy (Ed.), A guide to econometric (5th ed., pp. 281–284). Cambridge, MA: The MIT Press.
40.
go back to reference Soubrane, G., Cruess, A., Lotery, A., et al. (2007). Burden and health care resource utilization in neovascular age-related macular degeneration: Findings of a multicountry study. Archives of Ophthalmology, 125(9), 1249–1254.PubMedCrossRef Soubrane, G., Cruess, A., Lotery, A., et al. (2007). Burden and health care resource utilization in neovascular age-related macular degeneration: Findings of a multicountry study. Archives of Ophthalmology, 125(9), 1249–1254.PubMedCrossRef
41.
go back to reference Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095–1108.PubMedCrossRef Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095–1108.PubMedCrossRef
42.
go back to reference Mangione, C. M., Lee, P. P., Pitts, J., et al. (1998). Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Archives of Ophthalmology, 116(11), 1496–1504.PubMed Mangione, C. M., Lee, P. P., Pitts, J., et al. (1998). Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Archives of Ophthalmology, 116(11), 1496–1504.PubMed
43.
go back to reference Austin, P. C., Escobar, M., & Kopec, J. A. (2000). The use of the Tobit model for analyzing measures of health status. Quality of Life Research, 9(8), 901–910.PubMedCrossRef Austin, P. C., Escobar, M., & Kopec, J. A. (2000). The use of the Tobit model for analyzing measures of health status. Quality of Life Research, 9(8), 901–910.PubMedCrossRef
44.
go back to reference Greene, W. H. (2003). Econometric analysis (5th ed.). Upper Saddle River, NJ: Prentice Hall. Greene, W. H. (2003). Econometric analysis (5th ed.). Upper Saddle River, NJ: Prentice Hall.
45.
go back to reference SAS. Version 9.2. (2008). Cary, North Carolina: SAS Institute Inc. SAS. Version 9.2. (2008). Cary, North Carolina: SAS Institute Inc.
47.
go back to reference Forster, M. (2002). Predictive accuracy as an achievable goal of science. Philosophy of Science, 69(s3), S124–S134.CrossRef Forster, M. (2002). Predictive accuracy as an achievable goal of science. Philosophy of Science, 69(s3), S124–S134.CrossRef
48.
go back to reference Mooney, C. Z., & Duval, R. D. (1995). Bootstrapping: A nonparametric approach to statistical inference. Newbury Park, CA: Sage. Mooney, C. Z., & Duval, R. D. (1995). Bootstrapping: A nonparametric approach to statistical inference. Newbury Park, CA: Sage.
49.
go back to reference MacKinnon, J. G. (2002). Bootstrap inference in econometrics. Canadian Journal of Economics, 35(4), 615–645.CrossRef MacKinnon, J. G. (2002). Bootstrap inference in econometrics. Canadian Journal of Economics, 35(4), 615–645.CrossRef
50.
go back to reference Howell, D. C. (2008). The analysis of missing data. In W. Outhwaite & S. Turner (Eds.), Handbook of social science methodology. London: Sage. Howell, D. C. (2008). The analysis of missing data. In W. Outhwaite & S. Turner (Eds.), Handbook of social science methodology. London: Sage.
51.
go back to reference Briggs, A. H. (2000). Handling uncertainty in cost-effectiveness models. Pharmacoeconomics, 17, 479–500.PubMedCrossRef Briggs, A. H. (2000). Handling uncertainty in cost-effectiveness models. Pharmacoeconomics, 17, 479–500.PubMedCrossRef
52.
go back to reference Huang, I. C., Frangakis, C., Atkinson, M. J., et al. (2008). Addressing ceiling effects in health status measures: A comparison of techniques applied to measures for people with HIV disease. Health Services Research, 43(1p1), 327–339.PubMedCrossRef Huang, I. C., Frangakis, C., Atkinson, M. J., et al. (2008). Addressing ceiling effects in health status measures: A comparison of techniques applied to measures for people with HIV disease. Health Services Research, 43(1p1), 327–339.PubMedCrossRef
53.
go back to reference Gold, M. R., Franks, P., McCoy, K. I., & Fryback, D. G. (1998). Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Medical Care, 36(6), 778–792.PubMedCrossRef Gold, M. R., Franks, P., McCoy, K. I., & Fryback, D. G. (1998). Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Medical Care, 36(6), 778–792.PubMedCrossRef
54.
go back to reference Macran, S., Weatherly, H., & Kind, P. (2003). Measuring population health: a comparison of three generic health status measures. Medical Care, 41(2), 218–231.PubMedCrossRef Macran, S., Weatherly, H., & Kind, P. (2003). Measuring population health: a comparison of three generic health status measures. Medical Care, 41(2), 218–231.PubMedCrossRef
55.
go back to reference Luo, N., Chew, L. H., Fong, K. Y., et al. (2003). A comparison of the EuroQol-5D and the Health Utilities Index mark 3 in patients with rheumatic disease. Journal of Rheumatology, 30(10), 2268–2274.PubMed Luo, N., Chew, L. H., Fong, K. Y., et al. (2003). A comparison of the EuroQol-5D and the Health Utilities Index mark 3 in patients with rheumatic disease. Journal of Rheumatology, 30(10), 2268–2274.PubMed
56.
go back to reference McIntosh, L., Kymes, S. M., Perron, B. B. M., et al. (2008). Truth and consequences: Assessing the relationship between health and vision related quality of life. Eyes on Innovation, the ARVO 2008 Annual Meeting. April 27–May 1. Fort Lauderdale, Florida. McIntosh, L., Kymes, S. M., Perron, B. B. M., et al. (2008). Truth and consequences: Assessing the relationship between health and vision related quality of life. Eyes on Innovation, the ARVO 2008 Annual Meeting. April 27–May 1. Fort Lauderdale, Florida.
Metagegevens
Titel
Predicting EQ-5D utility scores from the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ 25) in patients with age-related macular degeneration
Auteurs
Nalin Payakachat
Kent H. Summers
Andreas M. Pleil
Matthew M. Murawski
Joseph Thomas III
Kristofer Jennings
James G. Anderson
Publicatiedatum
01-09-2009
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 7/2009
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-009-9499-6

Andere artikelen Uitgave 7/2009

Quality of Life Research 7/2009 Naar de uitgave